Yungjin Pharm Co Ltd (003520) - Total Liabilities

Latest as of September 2025: ₩156.23 Billion KRW ≈ $105.88 Million USD

Based on the latest financial reports, Yungjin Pharm Co Ltd (003520) has total liabilities worth ₩156.23 Billion KRW (≈ $105.88 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 003520 cash generation efficiency to assess how effectively this company generates cash.

Yungjin Pharm Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Yungjin Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Yungjin Pharm Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Yungjin Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Yungjin Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Sound Point Meridian Capital, Inc. NYSE:SPMC	USA	$195.07 Million
Korea Asset In Trust Co Ltd KO:123890	Korea	₩659.09 Billion
Europap Tezol Kagit Sanayi Ve Ticaret AS IS:TEZOL	Turkey	TL1.22 Billion
Yg Plus Inc KO:037270	Korea	₩103.63 Billion
Brightstar Resources Ltd AU:BTR	Australia	AU$74.05 Million
Cantabil Retail India Limited NSE:CANTABIL	India	Rs6.63 Billion
Nextgreen Global Bhd KLSE:7241	Malaysia	RM245.65 Million
Voyager Therapeutics Inc NASDAQ:VYGR	USA	$68.49 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Yungjin Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yungjin Pharm Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.74	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yungjin Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yungjin Pharm Co Ltd (2013–2024)

The table below shows the annual total liabilities of Yungjin Pharm Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩144.45 Billion ≈ $97.89 Million	+5.47%
2023-12-31	₩136.97 Billion ≈ $92.82 Million	+20.98%
2022-12-31	₩113.21 Billion ≈ $76.72 Million	+26.91%
2021-12-31	₩89.21 Billion ≈ $60.46 Million	+21.10%
2020-12-31	₩73.67 Billion ≈ $49.92 Million	-13.02%
2019-12-31	₩84.69 Billion ≈ $57.40 Million	+0.22%
2018-12-31	₩84.51 Billion ≈ $57.27 Million	+0.37%
2017-12-31	₩84.20 Billion ≈ $57.06 Million	-9.65%
2016-12-31	₩93.19 Billion ≈ $63.15 Million	-0.09%
2015-12-31	₩93.27 Billion ≈ $63.21 Million	+19.30%
2014-12-31	₩78.18 Billion ≈ $52.98 Million	+16.88%
2013-12-31	₩66.89 Billion ≈ $45.33 Million	--

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$217.03 Million

₩320.24 Billion KRW

Market Cap Rank

#16256 Global

#675 in Korea

Share Price

₩1751.00

Change (1 day)

-1.07%

52-Week Range

₩1700.00 - ₩2360.00

All Time High

₩17500.00